van Veldhuizen H W, Hummelen J W, Chakhssi F
Tijdschr Psychiatr. 2021;63(4):263-269.
There is limited knowledge of the predictive validity of risk factors and protective factors for recidivism in forensic psychiatric patients with an autism spectrum disorder (ASD).
To examine risk factors, protective factors and the predictive value of these factors in relation to recidivism for forensic psychiatric patients with ASD compared to patients without ASD.
For 69 patients, including 32 patients with ASD, the risk factors and protective factors were measured at the start and end of treatment. Of these 69 patients recidivism was examined for 23 patients, including 10 patients with ASD. Furthermore, the predictive validity of these measurements in relation to recidivism was explored.
The positive changes on risk and protective factors at the end of treatment did not differ significantly between both groups, except for the external protective factor, on which patients with ASD scored less favourable. We used a follow-up period of 2.5 to 4 years. Only 1 out of 10 ASS-patient showed recidivism compared to 7 out of 13 in the non-ASD-group. The scores on the risk assessment instruments at the start of treatment showed a significant predictive validity for recidivism, the scores at the of the end treatment did not. Structured clinical judgment of recidivism showed no significant predictive validity at the start as well as the end of treatment.
Despite the small sample, the results give rise to further research about risk factors and protective factors for recidivism, and the usability of risk-assessment for forensic patients with ASD.
对于患有自闭症谱系障碍(ASD)的法医精神病患者,再犯风险因素和保护因素的预测效度方面的了解有限。
与无ASD的患者相比,研究患有ASD的法医精神病患者的再犯风险因素、保护因素以及这些因素的预测价值。
对69名患者进行研究,其中包括32名患有ASD的患者,在治疗开始和结束时测量其风险因素和保护因素。在这69名患者中,对23名患者进行了再犯情况检查,其中包括10名患有ASD的患者。此外,还探讨了这些测量与再犯之间的预测效度。
除外部保护因素外,两组患者在治疗结束时风险和保护因素的积极变化无显著差异,ASD患者在外部保护因素上得分较低。我们采用了2.5至4年的随访期。10名患有ASD的患者中只有1人出现再犯,而非ASD组的13名患者中有7人出现再犯。治疗开始时风险评估工具的得分对再犯具有显著的预测效度,而治疗结束时的得分则不具有。结构化临床再犯判断在治疗开始和结束时均未显示出显著的预测效度。
尽管样本量较小,但研究结果促使人们进一步研究再犯的风险因素和保护因素,以及ASD法医患者风险评估的可用性。